Return to Search
EN
Phenylketonuria (PKU) treatment is critically important for the lifelong management of the disease. The primary groups who should receive treatment are:
* Newborns: For infants diagnosed with phenylketonuria as a result of newborn screening tests, diet therapy should be initiated immediately and under medical supervision to prevent long-term neurological and developmental problems.
* Women of Childbearing Age: Women with a family history of phenylketonuria who are planning a pregnancy must meticulously plan and maintain a special PKU diet in collaboration with their doctors before and during pregnancy to minimize the adverse effects of high phenylalanine levels on the unborn baby.
* Adults: Patients with phenylketonuria should receive lifelong dietary treatment to maintain their quality of life and prevent potential complications. It is crucial for adults who discontinue treatment for any reason to immediately contact healthcare professionals to re-plan and adhere to their diet.
Who should receive Phenylketonuria treatment?
* Newborns: For infants diagnosed with phenylketonuria as a result of newborn screening tests, diet therapy should be initiated immediately and under medical supervision to prevent long-term neurological and developmental problems.
* Women of Childbearing Age: Women with a family history of phenylketonuria who are planning a pregnancy must meticulously plan and maintain a special PKU diet in collaboration with their doctors before and during pregnancy to minimize the adverse effects of high phenylalanine levels on the unborn baby.
* Adults: Patients with phenylketonuria should receive lifelong dietary treatment to maintain their quality of life and prevent potential complications. It is crucial for adults who discontinue treatment for any reason to immediately contact healthcare professionals to re-plan and adhere to their diet.